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IntroductIon
During myocardial infarction (MI), interruption of coro-
nary artery blood flow causes sterile cardiac injury. Although 
advances in medical and interventional management have 
improved outcomes after MI, many patients still develop 
progressive left ventricular dysfunction as a result of myo-
cyte loss, suboptimal healing, and adverse left ventricular re-
modeling. Thus, beyond current standard revascularization 
and neurohumoral blockade measures, we urgently need new 
approaches to minimize acute cardiac ischemic damage and 
optimize the healing response to maximize the avoidance of 
chronic ischemic cardiomyopathy.
Wound healing after MI involves a variety of molecu-
lar and cellular events that replace necrotic myocardial debris 
with granulation tissue and a collagen-rich scar (Prabhu and 
Frangogiannis, 2016). Ischemic injury triggers massive re-
cruitment of BM and spleen-derived neutrophils and mono-
cytes (Nahrendorf et al., 2007; Swirski et al., 2009; Dutta et 
al., 2012; Leuschner et al., 2012; Swirski and Nahrendorf, 
2013; Heidt et al., 2014; Hilgendorf et al., 2014a), which, 
upon accumulation, contribute to inflammation and repair by 
producing cytokines, proteases, reactive oxygen species, an-
giogenic substances, and growth factors. An optimal response 
should remove the irreversibly damaged myocytes while lim-
iting further ischemic damage and avoiding complications 
such as heart failure or left ventricular rupture. Understanding 
the endogenous immune inflammatory mechanisms that op-
erate during MI may identify strategies for avoiding ischemic 
cardiomyopathy, thus complementing current interventional 
and neurohumoral blockade approaches.
The multifunctional growth factor GM-CSF controls 
leukocyte production, proliferation, differentiation, and sur-
vival (Bradley and Metcalf, 1966; Hamilton, 2008; Becher 
et al., 2016). Although hematopoiesis under normal physio-
logical conditions does not require GM-CSF, its production 
rises substantially after injury, which is one reason that cur-
rent clinical trials target GM-CSF for diverse inflammatory 
conditions such as rheumatoid arthritis and multiple sclerosis 
(Hamilton et al., 2016; Wicks and Roberts, 2016). With the 
exception of a few inconclusive and contradictory findings, 
the role of GM-CSF in MI remains largely unresolved. For 
example, serum GM-CSF levels rise in patients with MI, 
correlating with severity of acute decompensated heart fail-
ure and subsequent cardiac remodeling (Parissis et al., 2000, 
2004), whereas exogenous GM-CSF administration exacer-
bates heart failure (Maekawa et al., 2004). In some patients, 
however, GM-CSF may be beneficial after MI by improving 
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neoangiogenesis (Seiler et al., 2001; Bruno et al., 2006). Here, 
we explored GM-CSF’s function in MI using human tissue 
and mice deficient in GM-CSF or its receptor (GM-CSFR). 
We demonstrate that GM-CSF impairs healing after MI by 
acting locally in the heart and at a distance in the BM to pro-
duce and recruit inflammatory leukocytes.
reSultS
GM-cSF is detrimental in MI
To explore GM-CSF’s function after MI, we first evaluated 
postinfarction survival. We found that WT mice died of car-
diac rupture in considerably higher numbers than Csf2−/− 
mice (Fig. 1 A). Among survivors, Csf2−/− mice had improved 
left ventricular systolic function 21 d after MI, as assessed by 
cardiac magnetic resonance imaging (MRI), despite similar 
initial (1 d post-MI) infarct size or left ventricular volume in 
the groups (Fig. 1, B and C; and Fig. S1 A). On histological 
examination, 7-d-old infarcts of Csf2−/− mice had reduced 
CD11b+ myeloid cell numbers, reduced collagen accumula-
tion, and smaller α smooth muscle actin areas, with no differ-
ences in CD31+ endothelial cell number (Fig. 1 D), whereas 
flow cytometry revealed attenuated neutrophil, Ly-6Chigh 
monocyte, and macrophage accumulation in Csf2−/− hearts 
3 and 7 d after MI (Fig.  1, E and F). At day 3, compared 
with WT, infarcts in Csf2−/− mice had much lower levels of 
mRNAs that encode inflammatory cytokines such as IL-1β, 
IL-6, and matrix metalloproteinase (MMP)-9 (Fig.  1  G). 
Though GM-CSF may promote macrophage apopto-
sis through IL-23 (Subramanian et al., 2015), we found no 
differences in IL-23 mRNA levels in the infarct (Fig. 1 G). 
Mice lacking the common β subunit of the GM-CSF re-
ceptor (CD131; Csf2rb) yielded similar results (Fig. S1 B). 
Administration of recombinant mouse GM-CSF to WT mice 
decreased survival while increasing leukocyte accumulation 
(Fig.  1, H and I), whereas administration of anti-GM-CSF 
neutralizing antibody protected WT mice from cardiac rup-
ture and improved survival during the first 4 wk after per-
manent coronary ligation (Fig. 1 J). These data suggest that 
endogenous GM-CSF causes impaired wound healing result-
ing from aggravated inflammation and enhanced leukocyte 
accumulation after MI.
cardiac fibroblasts produce GM-cSF in response to acute 
ischemic injury in both mice and humans
The striking improvements in survival and cardiac function, 
along with the attenuated inflammation, in mice lacking 
GM-CSF, prompted us to delve deeper into the orchestrating 
mechanisms. The infarct, and not the uninfarcted myocar-
dium, spleen, BM, and lymph nodes, augmented Csf2 mRNA, 
which peaked on day 1 and subsided thereafter (Fig.  2 A), 
suggesting a direct link between point of injury and GM-CSF 
induction. Expression of Il3 and Il5, the growth factors that 
also signal to Csf2rb, were undetectable and unchanged, re-
spectively, indicating an exclusive and dynamic GM-CSF/
GM-CSFR signaling dyad after MI (Fig. 2 B). Infarcted tis-
sue also produced abundant Csf2 protein in both WT and 
Csf2rb−/− mice (Fig. 2 C), reflecting robust local translation 
independent of GM-CSF signaling. That Csf2−/− mice did 
not produce any GM-CSF confirmed the integrity of the 
mouse strain and the assays used (Fig. 2 C).
The presence of the GM-CSF transcript in the heart ar-
gued in favor of the idea of a cardiac-resident cell population 
as the growth factor’s source. Using FACS, we identified four 
cell types in the heart (Fig. 2 D): leukocytes, which express 
CD45; endothelial cells, which do not express CD45 but 
are abundant for CD31; fibroblasts, which express the fibro-
blast-specific marker MEF SK4 (Pinto et al., 2016), along with 
other classic fibroblast-associated markers (Fig. 2, D and E); 
and so-called other stromal cells, which lack the aforemen-
tioned markers and thus comprise a mixture of cells, some 
of which are cardiomyocytes (Fig.  2, D and F). Strikingly, 
fibroblasts were the most abundant, and nearly exclusive, Csf2 
producers 1 d after coronary artery ligation (Fig. 2 G), with 
minor production by other cells and no production otherwise. 
The increase depended on a mixture of danger-associated 
molecular patterns given reduced GM-CSF production in 
Myd88−/−, Tlr9−/−, and Ticam1−/− mice (Fig. 2 H). To test 
whether cardiac fibroblasts can directly sense danger signals 
via TLR3 and TLR9, we sorted fibroblasts, placed them in 
culture, stimulated with the two TLR ligands alone or in 
combination, and measured GM-CSF in supernatants. Our 
in vitro data confirm that fibroblasts can produce GM-CSF 
through Ticam1-dependent (Tlr3) and Myd88-dependent 
(Tlr9) mechanisms, suggesting the importance of multiple 
signals for GM-CSF production (Fig. 2 I).
The data obtained in the mouse led us to consider 
whether infarcted human hearts likewise produce GM-CSF 
after MI. We obtained heart tissue specimens from deceased 
patients with infarcts that, upon pathological examination, 
were classified as acute (1–2 d because of C4d staining) or late 
(5–7 d, given signs of leukocyte accumulation and granula-
tion tissue formation). We also examined hearts from patients 
who died from causes unrelated to MI. Consistent with data 
obtained in the mouse, we found that the acutely infarcted 
myocardium, and not the late infarct or the uninfarcted myo-
cardium, contained GM-CSF+ cells. Of these, the majority 
were spindle-shaped cells that expressed vimentin, a mor-
phology and phenotype consistent with cardiac fibroblasts 
(Fig. 2, J–L). These data indicate that cardiac fibroblasts pre-
dominate as the source of GM-CSF in the acutely infarcted 
myocardium in both mice and humans.
GM-cSF recruits leukocytes after MI by 
stimulating chemokine production
Having established GM-CSF’s source, we next sought to 
determine whether GM-CSF influences the response to 
ischemic injury via local effects in the heart. Because of the 
correlation between GM-CSF expression and leukocyte ac-
cumulation, we reasoned that the growth factor may contrib-
ute to leukocyte accrual, which depends on influx, survival, 
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Figure 1. GM-cSF is detrimental in MI. (A) Post-MI survival rate in WT and Csf2−/− mice. Data are from three independent experiments. **, P < 0.01. 
(B) Representative MRI images showing infarct size with late gadolinium enhancement on 1 d and heart morphology at end-diastolic and end-systolic 
phases 21 d after MI in WT and Csf2−/− mice. Bars, 4 mm. (C) Quantification of infarct size at 1 d as well as individual changes in indicated parameters from 
1 to 21 d post-MI (n = 6–7 per group from two independent experiments). *, P < 0.05. (D) Immunohistochemical study of infarcted tissue for CD11b, collagen 
I, CD31, and α-smooth muscle actin (αSMA) in WT and Csf2−/− mice 7 d after MI. Quantification of 10 randomly assigned fields of view per sample (n = 5 
per group). Bar, 30 µm. *, P < 0.05; **, P < 0.01. (E) Representative flow dot plots of MI tissue cell suspensions before and 1, 3, and 7 d after MI in WT and 
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and proliferation. We eliminated the likelihood that GM-CSF 
promotes leukocyte survival (Fig. 3, A and B) and prolifer-
ation (Fig. 3 C), and thus focused on influx. We found that 
3-d-old infarcts in Csf2−/− mice expressed lower levels of 
Cxcl2, Ccl2, Ccl3, Ccl5, and Ccl7 compared with WT mice 
(Fig. 3 D). Among those chemokines that are GM-CSF de-
pendent, Cxcl2 attracts neutrophils whereas Ccl2, Ccl3, Ccl5, 
and Ccl7 attract Ly-6Chigh monocytes. Because we found no 
differences in expression of either neutrophil Cxcr2 (ligand 
for Cxcl2) or monocyte Ccr2 (ligand for Ccl2) between WT 
and Csf2rb−/− mice (Fig. 3 E), we concluded that GM-CSF–
dependent effects on recruitment, if any, likely rely on the 
attracting chemokines produced in the heart.
To explore neutrophil recruitment, we profiled Cxcl1 
and Cxcl2. We found that cardiac fibroblasts produced abun-
dant levels of GM-CSF–independent Cxcl1, whereas leuko-
cytes were the largest source of GM-CSF–dependent Cxcl2 
(Fig.  4  A). Among the leukocytes, neutrophils generated 
considerable Cxcl2, and Csf2rb−/− neutrophils expressed 
significantly less Cxcl2 compared with WT cells (Fig. 4 B). 
These data collectively indicate that enhanced neutrophil ac-
cumulation is a function of increased recruitment rather than 
survival. This recruitment is driven by GM-CSF, which stim-
ulates neutrophil-attracting Cxcl2 production.
To explore monocyte recruitment, we profiled Ccl2. To 
determine Ccl2’s cellular source after MI, we took advan-
tage of Ccl2 reporter mice, in which all Ccl2+ cells express 
the fluorescent protein mCherry. mCherry+ cells appeared 
in 2-d-old infarcts, with minimal to no expression in naive 
hearts, blood cells, or cells in the BM (Fig.  4  C). Among 
the cardiac Ccl2 producers, myeloid cells, such as Ly-6Chigh 
monocytes and macrophages, predominated, with additional 
contribution from neutrophils and cardiac fibroblasts (Fig. 4, 
C and D). In Ccr2−/− mice, which have profoundly reduced 
numbers of circulating monocytes, Ccl2 production in the 
heart was diminished, along with diminished monocyte and 
macrophage accumulation, further substantiating the idea 
that monocytes are Ccl2 sources (Fig.  4  E). Ccl2 produc-
tion depended on signaling via GM-CSFR (Fig. 4 F), thus 
recapitulating observations made in Csf2−/− mice (Fig. 3 D). 
In vitro, GM-CSF strongly stimulated Ccl2 production from 
sorted Ly-6Chigh monocytes and macrophages. We also pro-
filed cells from Csf2rb−/− mice as controls and found no Ccl2 
production in response to GM-CSF, indicating a direct, spe-
cific stimulation (Fig. 4 G). However, neither neutrophils nor 
fibroblasts produced additional Ccl2 upon GM-CSF stimu-
lation, indicating that Ccl2 production in these cells involves 
GM-CSF–independent pathways. To dig deeper, we found 
phosphorylated STAT5 in Ly-6Chigh monocytes and macro-
phages, indicating GM-CSF signaling (Fig. 4 H). Finally, we 
adoptively transferred Ly-6Chigh monocytes from GFP+ mice 
into WT and Csf2−/− animals subjected to coronary ligation 
3 d earlier. Even though the same number of GFP+ cells were 
injected, we retrieved far fewer GFP+ cells from Csf2−/− in-
farcts (Fig. 4, I and J). Our data show that cardiac GM-CSF at-
tracts monocytes to the heart by stimulating Ccl2 production.
GM-cSF promotes accumulation of proteolytic and 
inflammatory neutrophils and monocytes after MI
Our data thus far indicate that GM-CSF promotes leuko-
cyte influx to the infarcted myocardium via neutrophil- and 
monocyte-attracting chemokine production. We next tested 
whether GM-CSF influences leukocyte function. We elected 
to profile inflammatory and proteolytic activity, as these can 
disrupt wound repair (Nahrendorf et al., 2007; Hilgendorf 
et al., 2014a) and contribute to left ventricular heart rupture 
(Heymans et al., 1999; Matsumura et al., 2005), respectively. 
Using a probe that reports on proteolytic activity (Nahren-
dorf et al., 2007), we found considerably reduced proteolysis 
in Csf2−/− mice (Fig. 5, A and B). Among the cells, Ly6Chigh 
monocytes and neutrophils contributed comparably to prote-
olysis, but the highest proteolytic activity tracked with mac-
rophages (Fig. 5, C and D). Importantly, all three cell types 
had reduced proteolytic activity in Csf2−/− mice. In keeping 
with these observations, we likewise detected reduced expres-
sion of Il1β, Il6, and Mmp9 in sorted neutrophils, Ly-6Chigh 
monocytes, and macrophages of Csf2rb−/− mice, compared 
with WT mice (Fig. 5 E). Together, these data indicate that 
GM-CSF not only induces monocyte and neutrophil influx 
but is also important to leukocyte function, including prote-
olysis and inflammation.
GM-cSF stimulates BM hematopoiesis by acting on cd131+ 
multipotent progenitors after MI
Having shown the local action of GM-CSF, we next consid-
ered whether the growth factor also acts systemically. In sup-
port of this idea, GM-CSF protein levels increased in serum 
and BM 1 and 2 d after coronary artery ligation (Fig. 6, A 
and B). To determine whether heart-derived GM-CSF can 
influence the BM via the circulation, we joined WT mice 
Csf2−/− mice. (F) Flow cytometry–based quantification of indicated cells in the hearts of WT and Csf2−/− mice before and 1, 3, and 7 d after MI (n = 3–7 per 
group from at least two independent experiments). *, P < 0.05. (G) mRNA levels of indicated cytokines in the infarcted tissue of WT and Csf2−/− mice 3 d 
after MI (n = 5–8 per group from three independent experiments). *, P < 0.05. (H) Post-MI survival rate in recombinant mouse GM-CSF (rmGM-CSF)-injected 
and PBS-injected WT mice. Data are from three independent experiments. *, P < 0.05. (I) Flow cytometry–based quantification of indicated cells in the hearts 
of rmGM-CSF–injected and PBS-injected WT mice 3 d after MI (n = 7 per group from three independent experiments). *, P < 0.05; **, P < 0.01. (J) Post-MI 
survival rate in mice treated with anti–GM-CSF neutralization antibody and control IgG. Data are from three independent experiments. *, P < 0.05. For 
statistical analysis, log-rank test was applied to compare survival curves, and two-tailed unpaired t test was performed to compare two groups. Results 
are shown as mean ± SEM.
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Figure 2. GM-cSF is produced by cardiac fibroblasts after MI in mice and humans. (A) Csf2 mRNA levels in the infarcted tissue, uninfarcted tissue, 
spleen, BM, and mediastinal lymph node 1, 3, and 7 d after MI. Control mice were analyzed before MI (day 0; n = 3–5 per group from at least two inde-
pendent experiments). *, P < 0.05, **, P < 0.01 vs. control. (B) Il-3 and Il-5 mRNA expression levels in infarcted tissue 1, 3, and 7 d after MI. Control mice 
were analyzed before MI (day 0; n = 5–6 per group from two independent experiments). (C) GM-CSF protein concentration in the heart homogenate of 
WT, Csf2−/−, and Csf2rb−/− mice 1, 3, and 7 d after MI. Control mice were analyzed before MI (day 0; n = 3–5 per group from two independent experiments) 
*, P < 0.05, **, P < 0.01 vs. control. (D) Flow cytometric gating strategy to determine total leukocytes (Leuk), endothelial cells (ECs), fibroblasts (FBs), and 
other stromal cells (Other) in the heart. (E) Expression levels of genes encoding periostin (Postn), platelet-derived growth factor receptor-α (Pdgfra), and 
collagen 1a1 (Col1a1) in infarcted tissue and indicated cells sorted from infarcted myocardium 1 d after MI. Values are normalized by gene levels in tissue 
(n = 5–6 per group from two independent experiments). (F) Gene levels of Myh6, which is specific for cardiomyocytes, in the heart tissue and the sorted 
heart subpopulations defined in D before and 1 d after MI. Data were normalized to 0 d tissue (n = 5–6 per group from two independent experiments). 
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with either WT or Csf2rb−/− partners by parabiosis, waited 14 
d to establish equilibrium (Theurl et al., 2016), subjected the 
WT mouse to coronary ligation, and performed a 2-h BrdU 
pulse-chase experiment 2 d later (Fig. 6 C). Compared with 
non-MI controls, we found higher Ly-6Chigh monocyte pro-
duction rates in WT partner BM (i.e., WT partner of a WT 
mouse that underwent coronary ligation), indicating that MI 
can stimulate hematopoiesis via the blood. Csf2rb−/− partners, 
in contrast, showed blunted production (Fig. 6 C), indicating 
that infarct-derived GM-CSF travels through the circulation 
to stimulate BM hematopoiesis.
To elucidate GM-CSF’s specific target, we examined 
CD131 (i.e., Csf2rb) expression among hematopoietic stem 
progenitor cells and found a distinct CD131+ population 
within Lin–ckit+Sca1+ LSK that was flk2–CD48+CD150–, 
and thus akin to the recently described myeloid-biased 
MPP3s (Pietras et al., 2015; Fig. 7 A and Fig. S2). In vitro 
experiments using different LSK subpopulations stimulated 
with GM-CSF supported this observation and further re-
vealed that MPP3s responded most to GM-CSF (Fig. 7 B), 
giving rise to GMP and MDP (Fig. 7 C) before becoming 
CD11b+ mature myeloid cells, comprised of monocytes/
macrophages (CD11b+ CD115+ Ly6G–) and neutrophils 
(CD11b+ CD115–Ly6G+; Fig. 7 D). In vivo, CD131+ MPP3s 
augmented proliferation in WT mice 2 d after MI, whereas 
CD131– MPP3s and CD131+ (and CD131–) MPP3s from 
Csf2−/− mice proliferated at baseline rates (Fig.  7  E). In 
agreement with these data, Csf2rb−/− mice had a lower 
(G) Csf2 mRNA expression levels in the sorted heart subpopulations defined in D before and 1 d after MI (n = 4–5 mice from at least two independent experi-
ments). *, P < 0.05 vs. 0 d. (H) Csf2 mRNA expression levels in infarcted tissue of WT, Myd88−/−, Tlr2−/−, Tlr4−/−, Tlr7−/−, Tlr9−/−, Il1r−/−, and Ticam1−/− (the gene 
that encodes TRIF) mice 1 d after MI (n = 4–8 mice from two to three independent experiments). *, P < 0.05 vs. WT heart. (I) GM-CSF protein concentration in 
supernatants of cardiac fibroblasts cultured in the presence or absence of TLR3 or TLR9 agonists (n = 4–6 per group from at least two independent experi-
ments). (J) Representative immunohistochemical images of C4d staining in heart sections of patients with or without MI. Acute and late infarcts indicate the 
heart sections from patients who died within 2 d (acute) or 7 d (late) after MI onset. Bars, 1 mm. (K) Identification of GM-CSF+ vimentin+ cardiac fibroblasts 
(white arrows) in C4d+ area indicated by the square in J. Bars, 20 µm. (L) Quantification of GM-CSF+ cells in heart sections of patients with or without MI. 
Cells were counted in 25 randomly selected fields of view per sample. **, P < 0.01, ***, P < 0.001 vs. no MI; ##, P < 0.01 vs. vimentin−. For statistical analysis, 
two-tailed unpaired t test was performed to compare two groups, and one-way ANO VA followed by Tukey’s test was performed for multiple comparisons. 
Results are shown as mean ± SEM.
Figure 3. GM-cSF promotes chemokine 
expression, but does not affect cell survival 
and proliferation in infarcted myocardium. 
(A) Representative flow cytometric dot plots 
of activated caspase 3 expression in WT and 
Csf2−/− macrophages, Ly-6Chigh monocytes, 
and neutrophils in infarcted tissue 3 d after 
MI. (B) Flow cytometry–based quantification 
of activated caspase 3+ cells shown in A (n = 4 
per group from two independent experiments). 
(C) Flow cytometric analysis of BrdU incorpo-
ration into WT and Csf2−/− macrophages in the 
infarcted tissue 3 d after MI. BrdU was injected 
2 h before death (n = 5 per group from two 
independent experiments). (D) Gene expres-
sion levels of Cxcl1, Cxcl2, Ccl2, Ccl3, Ccl5, 
Ccl7, and Cx3cl1 in 3-d-old infarcts of WT and 
Csf2−/− mice (n = 7–8 per group from three 
independent experiments). **, P < 0.01; NS, not 
significant. (E) Representative flow cytometric 
histograms for CXCR2 expression on blood 
neutrophils and CCR2 expression on blood 
Ly-6Chigh monocytes of WT and Csf2rb−/− mice 
3 d after MI. For statistical analysis, two-tailed 
unpaired t test was performed to compare two 
groups. Results are shown as mean ± SEM.
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percentage of BrdU+ BM MPP3s than WT mice 2 d after 
coronary artery ligation (Fig. 7 F). Moreover, experiments 
involving competitive adoptive transfer of CD131+ and 
CD131– MPP3s into WT mice with MI revealed a higher 
proportion of myeloid cells accumulating in the myocar-
dium that had differentiated from the CD131+ population, 
suggesting that CD131+ MPP3s have an enhanced capac-
ity for recruitment and differentiation into mature myeloid 
cells in response to myocardial ischemia (Fig.  7 G). Con-
sequently, the BM of WT mice had more neutrophils and 
Ly-6Chigh monocytes during MI than the BM of Csf2−/− 
and Csf2rb−/− mice (Fig. 7 H and Fig. S2 B).
We have previously demonstrated that the spleen 
contributes monocytes to the infarcted myocardium 1 d 
after MI (Swirski et al., 2009). In this study, we wondered 
whether the spleen may be contributing to accumulation 
on day 3, a time point at which we detected GM-CSF–
dependent differences. Whereas splenectomy at the time of 
infarction recapitulated the contribution of the reservoir in 
the early monocyte response on day 1, splenectomy on day 
2 showed no contribution of the spleen to leukocyte ac-
cumulation on day 3, indicating that GM-CSF–dependent 
leukocyte accumulation was spleen independent (Fig. S3, A 
and B). In agreement with these observations, neutrophils 
and Ly-6Chigh monocytes in the spleen were not altered in 
the absence of GM-CSF signaling 3 d after MI (Fig. S3 C). 
Together, these data reveal that GM-CSF produced in the 
heart can promote hematopoiesis in the BM by targeting a 
specific resident progenitor subset.
GM-cSF licenses BM-derived cells to cause left ventricular 
rupture and immunopathology after coronary artery ligation
Our data thus far indicate that GM-CSF alerts the hema-
topoietic compartment for increased inflammatory cell 
production and recruitment after MI. We next sought to 
determine whether hematopoietic cells were indeed re-
sponsible for the difference in survival between WT and 
Csf2−/− mice, as depicted in Fig.  1. To this end, we gen-
erated three types of BM chimeras: lethally irradiated WT 
mice reconstituted with WT or Csf2rb−/− BM cells (hereaf-
ter termed WTWT and WTCsf2rb−/−, respectively) and lethally 
irradiated Csf2rb−/− mice reconstituted with WT BM cells 
(Csf2rb−/−WT). After coronary artery ligation, we observed 
increased Csf2 in WTWT mice (Fig. 8 A), along with abun-
dant leukocyte, neutrophil, and Ly-6Chigh monocyte accu-
mulation in both WTWT and Csf2rb−/−WT mice (Fig. 8 B). In 
contrast, fewer leukocytes accumulated in WTCsf2rb−/− mice, 
suggesting that GM-CSF–dependent increases in leukocyte 
numbers were linked directly to hematopoiesis. To test this 
conjecture, we enumerated cells in the BM, and observed 
that BM cells lacking the GM-CSF receptor failed to gener-
ate progenitors and mature myeloid cells in addition to those 
generated in the basal state (Fig. 8 C). Moreover, infarcts of 
WTCsf2rb−/− mice contained lower mRNAs encoding the 
inflammatory mediators Il-1β, Il-6, Mmp9, and Ccl2 than 
those in the other groups (Fig. 8 D). Finally, when followed 
for 4 wk after coronary ligation, WTCsf2rb−/− mice survived 
longer compared with the other two groups (Fig. 8 E). Col-
lectively, these data indicate that GM-CSF reduces survival 
by acting on hematopoietic cells.
dIScuSSIon
Many studies have implicated leukocytosis, and specifically 
the rise of neutrophils and monocytes, as independent risk 
factors in cardiovascular disease (Kyne et al., 2000; Brown et 
al., 2001; Hajj-Ali et al., 2001; Maekawa et al., 2002; Madjid 
et al., 2004; Tsujioka et al., 2009; Nahrendorf et al., 2010). In 
experimental MI, excessive myeloid cell accumulation likely 
contributes to adverse cardiac remodeling and death (Panizzi 
et al., 2010; Kempf et al., 2011; Anzai et al., 2012), whereas 
hearts with reduced leukocyte infiltration heal and function 
better than controls (Romson et al., 1983; Kaikita et al., 2004; 
Leuschner et al., 2010). Apoe−/− mice, which develop mono-
cytosis (Swirski et al., 2007) by augmenting responsiveness 
to GM-CSF (Murphy et al., 2011), have detrimental wound 
healing and accelerated heart failure after MI (Panizzi et al., 
Figure 4. GM-cSF recruits neutrophils and monocytes after MI by stimulating cxcl2 and ccl2 production. (A) Gene levels of Cxcl1 and Cxcl2 in 
the sorted heart subpopulations 3 d after MI. Data were normalized to Leuk (n = 4 per subpopulation from two independent experiments). (B) Cxcl2 mRNA 
expression levels in neutrophils, Ly-6Chigh monocytes, and macrophages sorted from 3-d-old infarcts of WT and Csf2rb−/− mice (n = 6 per population from 
at least two independent experiments). *, P < 0.05. (C) Representative flow cytometric images for mCherry expression in B6.Cg-Ccl2tm1.1Pame/J mouse heart, 
blood, and BM before and 2 d after MI. (D) Pie chart showing percentage distribution of mCherry+ cells for the indicated subpopulations in infarcted myo-
cardium 2 d after MI. (E) Ccl2 mRNA expression in infarct and enumeration of indicated cells in the hearts of WT and Ccr2−/− mice 3 d after MI (n = 4–6 per 
group from two independent experiments). *, P < 0.05. (F) Ccl2 mRNA expression in WT and Csf2rb−/− Ly-6Chigh monocytes and macrophages in MI tissue 2 d 
after MI (n = 9–10 per group from at least three independent experiments). ***, P < 0.001. (G) Ly-6Chigh monocytes, macrophages, neutrophils, and fibroblasts 
were sorted from 2-d-old infarct of WT or Csf2rb−/− mice and cultured in the presence or absence of GM-CSF for 48 h. GM-CSF protein levels were measured 
in the supernatants. Values are normalized to WT with medium (n = 5–6 per group from two independent experiments). **, P < 0.01. (H) Representative 
flow cytometric histograms for pSTAT5 expression in the indicated cells. Single cell suspension from hearts 2 d after MI was incubated with or without 
GM-CSF and stained with pSTAT5. (I) Illustration of experimental approach with adoptive transfer of sorted GFP+ BM Ly-6Chigh monocytes (3 × 106) into WT 
or Csf2−/− mice 3 d after permanent coronary ligation. (J) Representative flow dot plots of infarcted hearts of WT and Csf2−/− mice for GFP+ cells 3 h after 
the transfer. Quantification of GFP+ cells in the hearts of indicated animals is also shown (n = 4 per group from two independent experiments). *, P < 0.05. 
For statistical analysis, two-tailed unpaired t test was performed to compare two groups, and one-way ANO VA followed by Tukey’s test was performed for 
multiple comparisons. Results are shown as mean ± SEM.
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2010). The BM, and to a lesser extent the spleen, manufac-
tures neutrophils and monocytes through myelopoiesis, and 
although billions of cells are made every day in the steady 
state, output rises in response to injury or infection. Given 
leukocytes’ central role in post-MI inflammation and repair, 
identifying signals that contribute to increased cell produc-
tion has high importance.
Our study’s findings, that GM-CSF controls neutro-
phil and monocyte production by acting on a specific BM 
progenitor, have several implications that extend beyond MI. 
Unlike M-CSF, the related growth factor that controls my-
eloid cell production in the steady state, GM-CSF contributes 
little to homeostatic hematopoiesis; mice lacking GM-CSF or 
its receptor have normal leukocyte levels and, aside from de-
veloping alveolar proteinosis as a result of defective surfactant 
clearance, have no demonstrable abnormalities. That said, ac-
cumulating evidence shows that the growth factor propels the 
inflammatory cascade. Our data contribute to this concept 
by demonstrating that GM-CSF–dependent leukocytosis re-
lies not so much on a general increase in cell production as 
on a specific GM-CSFR–expressing subset within the MPP3 
progenitor (Pietras et al., 2015). The BM, it seems, remains 
poised in a state of alert for GM-CSF should a need for in-
creased cell production arise.
Once generated and released into the bloodstream, 
leukocytes follow chemotactic cues to find their destination 
tissue. Among the signals, the ischemic heart produces the 
chemokines Ccl2 (Hayashidani et al., 2003; Dewald et al., 
2005), which attracts Ccr2+ monocytes, and Cxcl2, which 
attracts neutrophils (Soehnlein and Lindbom, 2010). We dis-
covered that GM-CSF stimulates substantial Ccl2 and Cxcl2 
in the heart after ischemic injury. Though many cells produce 
Ccl2 and Cxcl2, Ly-6Chigh monocytes and macrophages are 
among the most abundant contributors of Ccl2, whereas neu-
trophils themselves produce Cxcl2. This provides for a paral-
lel, feed-forward response that ensures massive monocyte and 
neutrophil accumulation over a short period of time (Fig. 9). 
Although they are required for wound healing, an overabun-
dance of these cells results in excessive inflammation and pro-
teolysis, which eventually leads to heart failure and death.
Our previous studies in sepsis, pneumonia, and ath-
erosclerosis identified a B cell subset, which we called in-
nate response activator, as a major GM-CSF source (Rauch 
et al., 2012; Hilgendorf et al., 2014b; Weber et al., 2014). 
This study identified no GM-CSF–producing B cells in 
the heart or spleen. However, the observation that cardiac 
fibroblasts make GM-CSF is intriguing, as fibroblasts also 
produce GM-CSF in other heart-related inflammatory dis-
Figure 5. GM-cSF promotes accumulation 
of proteolytic and inflammatory neutrophils 
and monocytes. (A) Representative pictures 
of ex vivo fluorescence reflectance imaging 
using MMPSense 680 for WT and Csf2−/− in-
farcted hearts 3 d after MI. FI, fluorescent in-
tensity. (B) Quantification of MMP activity in 
3-d-old infarcts of WT and Csf2−/− mice (n = 
4–6 per group). *, P < 0.05. (C) Representative 
flow cytometric histograms for MMP activ-
ity in macrophages, Ly-6Chigh monocytes, and 
neutrophils. (D) Flow cytometry–based quanti-
fication of MMP activity (n = 4–6 per group). 
*, P < 0.05. (E) Gene expression levels of Il-1β, 
Il-6, and Mmp9 in neutrophils, Ly-6Chigh mono-
cytes, macrophages, and fibroblasts sorted 
from WT and Csf2rb−/− MI tissue 3 d after MI 
(n = 5–12 per group from three independent 
experiments). *, P < 0.05; **, P < 0.01. For sta-
tistical analysis, two-tailed unpaired t test was 
performed to compare two groups. Results 
are shown as mean ± SEM.
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eases, such as autoimmune myocarditis and Kawasaki disease 
(Wu et al., 2014; Stock et al., 2016). As nonhematopoietic 
cells, fibroblasts are strategically located to sense the cardiac 
microenvironment. During MI, when dying cardiomyo-
cytes release danger-associated molecular patterns (Mann, 
2015; Prabhu and Frangogiannis, 2016), cardiac fibroblasts 
can easily respond as they bear TLRs and other scaven-
ger receptors. Our data accordingly indicate that multiple 
signals converging on the adapter molecules MyD88 or 
TRIF trigger GM-CSF production in the infarcted heart, 
which helps to generate and recruit hematopoietic cells 
that fuel inflammation. Experiments involving chimeras 
lacking the GM-CSF receptor underscore the importance 
of GM-CSF’s action on the hematopoietic rather than the 
stromal compartments because left ventricular rupture ul-
timately depends on this dyad. This result should not be 
surprising given that inflammatory leukocytes are major 
sources of oxidases, proteases, and other factors that can 
antagonize the formation of a durable scar.
Drugs targeting GM-CSF or its receptor are available 
for human use, and several clinical trials are underway test-
ing the efficacy of anti–GM-CSF therapy in various inflam-
matory diseases (Hamilton et al., 2016; Wicks and Roberts, 
2016). As a mediator that governs production, recruitment, 
and function of myeloid cells after MI, GM-CSF should 
be considered a potential therapeutic target to foster sal-
utary healing of the ischemic myocardium and prevent 
ischemic cardiomyopathy.
MaterIalS and MetHodS
animals
C57BL/6 (WT), B6.SJL-PtprcaPepcb/BoyJ, C57BL/6-Tg(UBC-
GFP)30Scha/J (GFP+), B6.129P2(SJL)-Myd88tm1.1Defr/J, 
B6.129-Tlr2tm1Kir/J, B6(Cg)-Tlr4tm1.2Karp/J, B6.129S1-Tlr7tm1Flv/J, 
C57BL/6J-Tlr9M7Btlr/Mmjax, B6.129S7-Il1r1tm1/mx/J, 
C57BL/6J-Ticam1Lps2/J, B6.Cg-Ccl2tm1.1Pame/J, and B6.129S4- 
Ccr2tm1lfc/J (The Jackson Laboratory) were used in this study. 
Csf2−/− and Csf2rb−/− mice on C57BL/6 background (10 
generations) were bred in-house (Rauch et al., 2012; Hilgen-
dorf et al., 2014b; Weber et al., 2014). All experiments were 
conducted with male mice aged 8–16 wk at the time of 
death. All protocols were approved by the Animal Review 
Committee at Massachusetts General Hospital.
animal models and in vivo interventions
Myocardial infarction. MI was induced by permanent liga-
tion of the left anterior descending coronary artery (LAD) as 
previously described (Nahrendorf et al., 2007; Hilgendorf et 
al., 2014a). In brief, mice were anesthetized with isoflurane 
(2%/2 liters O2), intubated, and ventilated with an Inspira 
Advanced Safety Single Animal Pressure/Volume Controlled 
Ventilator (Harvard Apparatus). Left thoracotomy was per-
formed in the fourth intercostal space after shaving the chest 
wall. The left ventricle was visualized, and the LAD was li-
gated with monofilament 8-0 suture (Ethicon). The chest and 
skin were closed with a 7-0 nylon suture followed by removal 
of air from the thorax via a pleural catheter. The procedure 
was performed by the same surgeon blinded to genotypes.
BM transplantation. Naive C57BL/6 or Csf2rb−/− mice were 
lethally irradiated (950 cGy) and reconstituted with either 
WT or Csf2rb−/− BM cells to generate three groups: (a) 
WTWT (irradiated WT mice reconstituted with WT BM), (b) 
WTCsf2rb−/− (irradiated WT mice reconstituted with Csf2rb−/− 
BM), and (c) Csf2rb−/−WT (irradiated Csf2rb−/− mice recon-
stituted with WT BM). After 7–8 wk to allow reconstitution, 
the mice were subjected to MI surgery.
adoptive transfer. BM Ly-6Chigh monocytes were collected 
from C57BL/6-Tg(UBC-GFP)30Scha/J mice by flow- 
Figure 6. Infarct-derived GM-cSF stimulates BM cell proliferation via circulation. (A and B) GM-CSF protein levels in serum (A) and BM (B) at 
indicated time points after MI (n = 4 per group from two independent experiments). *, P < 0.05. (C) Diagram of the experimental design and quantification 
of percentage of BrdU+ BM Ly-6Chigh monocytes in the indicated noninfarcted parabionts before and 2 d after MI. 14 d after parabiosis surgery, MI was 
induced in WT mice (circle). Noninfarcted mice (WT or Csf2rb−/− mice with square) were analyzed 2 d post-MI. BrdU was injected into noninfarcted mice 2 h 
before death (n = 4–5 per group from at least two independent experiments). *, P < 0.05. For statistical analysis, two-tailed unpaired t test was performed 
to compare two groups, and one-way ANO VA followed by Tukey’s test was performed for multiple comparisons. Results are shown as mean ± SEM.
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Figure 7. cd131+ multipotent progenitor subset contributes to BM hematopoiesis in response to GM-cSF after MI. (A) Representative 
flow dot plots for CD131+ cells in BM LSK. (B) Cell numbers of sorted LSK subpopulations stimulated with GM-CSF for 8 d. The data were normalized 
by 5 × 103 that were initially seeded into the culture plate (n = 3–4 per group from two to three independent experiments). *, P < 0.05. (C and D) 
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assisted cell sorting after enrichment of cells negative for 
CD3, CD19, B220, NK1.1, and Ly6G using magnetic cell 
separation. At 3 d after MI, 3 × 106 GFP+ Ly-6Chigh mono-
cytes were injected intravenously into WT or Csf2−/− mice. 
For BM MPP3 transfer, CD131+ MPP3s were sorted from 
C57BL/6-Tg(UBC-GFP)30Scha/J mice (CD45.2+ GFP+), 
and CD131– MPP3s were sorted from C57BL/6 mice 
(CD45.2+ GFP−). Those cells were intravenously injected at a 
1:1 ratio (104 cells each) into B6.SJL-PtprcaPepcb/BoyJ 
(CD45.1+) mice subjected to MI 1 d earlier.
Parabiosis. Parabiosis surgery was performed as previously de-
scribed (Robbins et al., 2013). In brief, after shaving the cor-
responding lateral aspects of each mouse, matching skin 
incisions were made from behind the ear to the tail of each 
mouse, and the subcutaneous fascia was bluntly dissected to 
create 0.5 cm of free skin. The scapulae were sutured using 
mononylon 5.0 (Ethicon), and the dorsal and ventral skins 
were approximated by continuous suture. Mice were joined 
for 2 wk and then subjected to MI.
Brdu incorporation experiments. To assess cell proliferation, 1 
mg BrdU was injected intraperitoneally 2 or 24  h before 
death and subsequent organ harvest. BrdU flow kit (BD Bio-
sciences) was used to stain BrdU+ cells.
Splenectomy. Splenectomy was performed as previously de-
scribed (Swirski et al., 2009). In brief, during isoflurane anes-
thesia, the abdominal cavity of mice was opened, and the 
spleen vessels were cauterized. The spleen was carefully re-
moved. For control experiments, the abdomen was opened, 
but the spleen was not excised.
anti–GM-cSF neutralization antibody treatment. After coro-
nary ligation, mice were randomly allocated to either anti–
GM-CSF treatment or control IgG treatment groups. 
Neutralizing antibody against GM-CSF (MP1-22E9, eBio-
science; 300 µg) or control IgG2a (eBR2a, eBioscience; 300 
µg) was intravenously injected once a day for 3 d.
recombinant mouse GM-cS injection. Recombinant mouse 
GM-CSF (BioLegend; 20 µg/kg) was intravenously injected 
into mice after the MI surgery twice a day for 3 d. PBS 
was used as a control.
cardiac MrI
To assess cardiac function and morphology, MRI was per-
formed on days 1 and 21 after MI as described previously 
(Sager et al., 2015). Cine images of the left ventricular 
short axis were obtained by using a 7-Tesla horizontal bore 
Pharmascan (Bruker) and a custom-built mouse cardiac 
coil (Rapid Biomedical). Left ventricular volume, ejec-
tion fraction, and infarct size were acquired and calculated 
as previously described.
ex vivo fluorescence reflectance imaging
2 nmol of an MMP sensor (MMPSense-680; PerkinElmer) 
was intravenously injected into mice subjected to MI 2 d 
earlier. 24 h later, hearts were excised, and ex vivo fluores-
cence imaging was performed to interrogate magnitude and 
quality of MMP activity.
cell isolation
Peripheral blood was collected by retroorbital bleeding, and 
erythrocytes were lysed in RBC lysis buffer (BioLegend). 
Spleens, femurs, tibias, and hearts were excised after vascu-
lar perfusion with cold PBS. Minced spleen and flushed BM 
were strained through 40-µm nylon mesh (BD Biosciences). 
Spleen cell suspensions were further subjected to RBC lysis. 
The naive hearts or infarcted areas with the border zone were 
minced and digested with 450 U/ml collagenase I, 125 U/
ml collagenase XI, 60 U/ml DNase I, and 60 U/ml hyal-
uronidase (Sigma-Aldrich) in PBS for 1 h at 37°C with shak-
ing. Total viable cell numbers were counted using Trypan 
blue (Cellgro, Mediatech).
cell sorting. Single-cell suspensions of heart tissue and BM from 
indicated animals were made and stained to identify indicated 
cell populations. Cells were sorted on a FACS Aria II (BD Bio-
sciences) directly into either RLT buffer for subsequent RNA 
isolation or complete medium for cell culture experiments.
Flow cytometry
Single-cell suspensions were stained in PBS supplemented 
with sterile 2% FBS and 0.5% BSA. The following monoclo-
nal antibodies were used for flow cytometric analysis: anti- 
CD45 (30-F11), anti-CD45.1 (clone A20), anti-CD45.2 
(clone 104), anti-CD3e (clone 145-2C11), anti-CD90.2 
(clone 53–2.1), anti-CD19 (clone 6D5), anti-B220 (clone 
Representative flow cytometric plots 12 h (C) and 96 h (D) after placement of sorted BM MPP3s in medium containing GM-CSF. (E) Representative 
flow dot plots and quantification of BrdU+ CD131+ or CD131– MPP3s in WT and Csf2−/− mice at indicated time points (n = 5–6 per group from three 
independent experiments). BrdU was injected 24 h before death. *, P < 0.05. (F) Quantification of BrdU+ MPP3s in WT and Csf2rb−/− mice before 
and 2 d after MI (n = 5–6 per group from three independent experiments). BrdU was injected 24 h before death. *, P < 0.05. (G) Illustration of 
experimental setup and flow dot plots of CD45.2+ cells in infarcted myocardium with quantification. Injected CD45.2+ CD131+ MPP3s are detected 
as GFP+, whereas CD45.2+ CD131– MPP3s are shown as GFP– (n = 4–5 per group from two independent experiments). *, P < 0.05. (H) Time course 
of BM neutrophil and Ly-6Chigh monocyte numbers in WT, Csf2−/−, and Csf2rb−/− mice after MI (n = 4–7 per group from at least three independent 
experiments). *, P < 0.05. For statistical analysis, two-tailed unpaired t test was performed to compare two groups, and one-way ANO VA followed 
by Tukey’s test was performed for multiple comparisons. Results are shown as mean ± SEM.
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RA3-6B2), anti-NK1.1 (clone PK136), anti-Ly6G (clone 
1A8), anti–Ly-6C (AL-21), anti-MHC II (clone AF6-120.1), 
anti-F4/80 (clone BM8), anti-CD11b (clone M1/70,), anti- 
CD11c (clone HL3), anti-CD115 (clone AFS98), anti-Ter119 
(clone Ter-119), anti-CD34 (clone RAM34), anti-flk2 (clone 
A2F10), anti-CD150 (clone TC15-12F12.2), anti-Sca1 
(clone D7), anti–c-kit (clone 2B8), anti-CD48 (clone HM48-
1), anti-CD16/32 (clone 93), anti-Gr1 (clone RB6-8C5), 
anti-CD127 (clone A7R34), anti-CD131 (clone REA193), 
anti-CD31 (clone 390), anti-MEF SK4 (clone mEF-SK4), 
anti-CCR2 (clone 475301), anti-CXCR2 (clone TG11/
CXCR2), anti–activated caspase 3 (clone C92-605), pSTAT5 
(clone pY694), and isotype controls. Antibodies were pur-
chased from BioLegend, BD Biosciences, eBioscience, or 
Miltenyi Biotec. Viable cells were identified as unstained with 
Zombie Aqua (BioLegend).
Figure 8. GM-cSF licenses BM-derived cells to cause left ventricular rupture and immunopathology after coronary artery ligation. WT mice 
were lethally irradiated and reconstituted with BM cells from either WT or Csf2rb−/− mice (WTWT and WTCsf2rb−/− mice, respectively). Csf2rb−/−WT mice were 
made by reconstitution of irradiated Csf2rb−/− mice with WT BM. (A) Csf2 mRNA expression levels in infarcted tissue of WTWT mice before and 5 d after MI 
(n = 3–6 per group from two independent experiments). *, P < 0.05. (B) Flow cytometry–based quantification of indicated cells in the hearts of WTWT, 
WTCsf2rb−/−, and Csf2rb−/−WT mice before and 5 d after MI (n = 4–7 per group from at least two independent experiments). *, P < 0.05. (C) Quantification of 
indicated BM cell fractions of WTWT, WTCsf2rb−/−, and Csf2rb−/−WT mice before and 5 d after MI (n = 4–7 per group from at least two independent experiments). 
*, P < 0.05. (D) mRNA expression levels of Il-1β, Il-6, Mmp9, and Ccl2 in infarcted tissue of WTWT, WTCsf2rb−/−, and Csf2rb−/−WT mice 5 d after MI (n = 6–8 per 
group from at least two independent experiments). *, P < 0.05. (E) Post-MI survival rate after MI in WTWT, WTCsf2rb−/−, and Csf2rb−/−WT mice. Data are from 
three independent experiments. *, P < 0.05. For statistical analysis, log-rank test was applied to compare survival curves, two-tailed unpaired t test was per-
formed to compare two groups, and one-way ANO VA followed by Tukey’s test was performed for multiple comparisons. Results are shown as mean ± SEM.
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Staining strategies. For intracellular staining, cells were fixed 
and permeabilized with BD Cytofix/Cytoperm (BD Biosci-
ences) according to the manufacturer’s instructions. For 
pSTAT5 staining, cells were stimulated with or without 
GM-CSF–containing medium (20 ng/ml) for 30 min at 
37°C to induce phosphorylation of STAT5, followed by ad-
dition of 4% PFA solution (pH 7.4) to obtain a final concen-
tration of 2%. After fixation for 20 min, cells were resuspended 
in 1 ml ice-cold methanol to permeabilize. After 30 min of 
incubation at 4°C, cells were washed twice and stained with 
anti-pSTAT5 antibody as well as antibodies for extracellular 
antigens for 45 min at room temperature before a final wash 
and acquisition. Specifically, cardiac cells were defined as (1) 
Ly-6Chigh monocytes (CD45+Lin–CD11b+F4/80–Ly-6Chigh), 
(2) neutrophils (CD45+CD11b+Lin+F4/80–), (3) macro-
phages (CD45+Lin–CD11b+F4/80+Ly-6Clow), (4) endothelial 
cells (CD45–CD31+MEF SK4–), (5) fibroblasts (CD45–CD31–
MEF SK4+), and (6) other stromal cells (CD45–CD31–MEF 
SK4–). BM cells were defined as (1) monocytes (CD45+Lin–
CD11b+CD115+F4/80–), (2) neutrophils (CD45+Ly6G+CD-
11b+CD115–F4/80–MHC II–), (3) LTHSC (Lin2–ckit+Sca1+-
flk2–CD48–CD150+), (4) STHSC (Lin2–ckit+Sca1+flk2–CD48–
Figure 9. Proposed model. The cartoon depicts functions by which GM-CSF aggravates healing after MI. GM-CSF is produced by cardiac fibroblasts in re-
sponse to damage-associated molecular patterns (DAMP). Fibroblast-produced GM-CSF acts locally on myeloid cells, which promote chemokine-dependent 
leukocyte recruitment. Fibroblast-generated GM-CSF also acts at a distance in the BM, where it stimulates CD131+ MPP3 to produce proteolytic and 
inflammatory neutrophils and monocytes. Together, these local and systemic functions result in enhanced production and recruitment of cells that 
aggravate post-MI healing.
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CD150–), (5) MPP2 (Lin2–ckit+Sca1+flk2–CD48+CD150+), 
(6) MPP3 (Lin2–ckit+Sca1+flk2–CD48+CD150–), (7) MPP4 
(Lin2–ckit+Sca1+flk2+CD150–), (8) GMP (Lin2–ckit+Sca1–
CD34+CD16/32highCD115–), and (9) MDP (Lin2–ckit+Sca1–
CD34+CD16/32highCD115+). Lineages were defined as Lin: 
CD3, CD90.2, CD19, B220, NK1.1, Ter119, Ly6G; Lin2: 
CD3, CD90.2, CD19, B220, NK1.1, Ter119, Gr1, CD127, 
CD11c. Data were acquired on a LSR II and analyzed 
with FlowJo (Tree Star).
cell culture
For all cell culture experiments, cells were cultured in complete 
medium (RPMI-1640 supplemented with 10% FBS, 2 mM 
l-glutamine, 100 U/ml penicillin and streptomycin, 10 mM 
Hepes, 50 µM 2-mercaptoethanol, 1 mM sodium pyruvate, 
and 1× nonessential amino acids), and kept in a humidified 5% 
CO2 incubator at 37°C. To determine the effect of GM-CSF 
on CCL2 production, neutrophils, Ly-6Chigh monocytes, mac-
rophages, and fibroblasts were sorted from WT and Csf2rb−/− 
mice on the FACS Aria II, and 5 × 103 cells were seeded into 
96-well plates in 200 µl medium. After incubation with or 
without GM-CSF for 48 h, supernatants were collected, and 
CCL2 levels were measured by ELI SA. To identify the cellular 
target of GM-CSF in BM LSK compartment, 5 × 103 sorted 
LTHSC, STHSC, MPP2, MPP3, and MPP4 cells were cultured 
with and without GM-CSF for indicated periods, followed by 
counting and staining after retrieval from the 96-well plates. To 
determine the effect of danger signals on GM-CSF production 
in cardiac fibroblasts after MI, 3 × 104 cardiac fibroblasts sorted 
from 1-d-old infarct were plated onto 96-well plates in 200 µl 
medium and incubated in the presence or absence of poly(I:C) 
or CpG (InvivoGen) for 48 h. Supernatants were collected, and 
GM-CSF levels were measured by ELI SA.
reverse transcriptional Pcr
tissue. Total RNA was isolated using the RNeasy Mini kit (Qia-
gen) according to the manufacturer’s instructions. cDNA was 
generated from 1 µg total RNA per sample using High Capacity 
cDNA Reverse Transcription kit (Applied Biosystems).
cells. 2 × 104 total leukocytes, neutrophils, Ly-6Chigh mono-
cytes, macrophages, endothelial cells, fibroblasts, and other 
stromal cells were sorted from infarcted myocardium, and 
total RNA was extracted using the RNeasy Micro kit (Qia-
gen) followed by cDNA transcription. Quantitative real-time 
TaqMan PCR was performed using the following TaqMan 
primers (Applied Biosystems): Il-1β (Mm01336189_m1), 
Il-3 (Mm00439631_m1), Il-5 (Mm00439646_m1), Il-6 
(Mm00446190_m1), Mmp9 (Mm00442991_m1), Col1a1 
(Mm00801666_g1), Pdgfra (Mm00440701_m1), Postn 
(Mm01284919_m1), Csf2 (Mm01290062_m1), Cxcl1 
(Mm04207460_m1), Cxcl2 (Mm00436450_m1), Ccl2 
(Mm00441242_m1), Ccl3 (Mm00441259_g1), Ccl5 
(Mm01302427_m1), Ccl7 (Mm00443113_m1), Cx3cl1 
(Mm00436454_m1), Ccl2 (Mm00441242_m1), Myh6 
(Mm00440359_m1), Il-23a (Mm00518984_m1), and house-
keeping gene Gapdh (Mm99999915_g1). PCR was run on a 
7500 thermal cycler (Applied Biosystems), and data were 
quantified with the 2-ΔCt method.
Histological methods
Hearts from WT and Csf2−/− mice (7 d after MI) were embed-
ded in Tissue-Tek OCT compound (Sakura Finetek), frozen 
in 2-methylbutane (Thermo Fisher Scientific) cooled with 
dry ice, and sectioned into 6-µm slices. Immunohistochemis-
try was performed using antibodies against CD11b (dilution 
1:25, clone M1/70; BD Biosciences), collagen 1 (dilution 
1:50, ab21286; Abcam), CD31 (dilution 1:5, clone MEC13.3; 
BD Biosciences), and α-smooth muscle actin (dilution 1:50, 
ab5694; Abcam). Biotinylated rabbit anti–rat IgG (dilution 
1:100, BA4001) or biotinylated goat anti–rabbit IgG (dilution 
1:100, BA1000) followed by Vectastain Elite ABC HRP kit 
(PK-6100; all from Vector Laboratories) were applied to the 
sections, and AEC substrate chromogen (K3464; Dako/Agi-
lent) was used for color development. Human heart samples 
were obtained from autopsies performed in the Department 
of Pathology, Massachusetts General Hospital. The study was 
approved by the Human Subjects Institutional Review Board 
at Massachusetts General Hospital. Hearts from two patients 
who died within 2 d after MI (acute infarct), two patients 
who died 7 d after MI (late infarct), and two patients who 
died from other reasons outside the heart were used in this 
study. Samples were fixed in 10% formalin and embedded in 
paraffin for histological sectioning (4-µm-thick slices). After 
deparaffinization and heat-induced antigen retrieval, sections 
were blocked with 4% normal goat serum for 45 min and 
stained with rabbit anti–human C4d (dilution 1:50, 12-5000; 
American Research Products). For immunofluorescence 
staining, rabbit anti–human GM-CSF (dilution 1:100, bs-
3790R, Bioss) and guinea pig anti–human vimentin (dilution 
1:50, GP53; Progen) were incubated at 4°C overnight, fol-
lowed by secondary antibodies, DyLight680 goat anti–rabbit 
IgG (dilution 1:100, 35568; Thermo Fisher Scientific) and bi-
otinylated anti–guinea pig IgG (dilution 1:100, BA7000, Vec-
tor Laboratories). To detect vimentin, streptavidin Dylight594 
(dilution 1:600, SA-5594; Vector Laboratories) was applied, 
and nuclei were counterstained by DAPI (D12490; Thermo 
Fisher Scientific). Images were captured by using a BX63 au-
tomated fluorescence microscope (Olympus).
elI Sa
GM-CSF levels were measured in heart homogenates, serum, 
and BM fluids with the Mouse GM-CSF ELI SA kit (R&D 
Systems). CCL2/MCP-1 levels were measured in cell culture 
supernatants with the CCL2 ELI SA kit (R&D Systems) ac-
cording to the manufacturer’s instructions.
Statistics
Results are shown as mean ± SEM. Statistical tests included 
unpaired, two-tailed nonparametric Mann–Whitney tests 
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(when Gaussian distribution was not assumed) or unpaired, 
two-tailed parametric t tests with Welch’s correction (when 
Gaussian distribution was assumed). For multiple compari-
sons, nonparametric multiple comparisons test comparing 
mean rank of each group (when Gaussian distribution was 
not assumed) or one-way ANO VA followed by Tukey’s test 
were performed. Survival distributions were estimated by the 
Kaplan–Meier method and compared by the log-rank test. P 
values of 0.05 or less were considered to denote significance.
online supplemental material
Fig. S1 shows additional readouts from MRI and cell quan-
tification. Fig. S2 shows gating strategies for HSPCs. Fig. S3 
shows experiments using splenectomy.
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